Points to consider on the Reduction, elimination or substitution of thiomersal in vaccines
Revised Version of Annex 14 - Manufacture of medicinal products derived from human blood or plasma to the EU Guide to Good Manufacturing Practice Fertiggestellt im Februar 2000